Cardiol Therapeutics Inc. CRDL, a clinical-stage life sciences company, reported results from its Phase II open-label MAvERIC ...
(TSX: CRDL) has seen success under a phase II trial conducted on CardiolRx, which is the company’s lead small molecule drug ...
Look at Cardiol Therapeutics, for example. At the moment, the company is developing novel therapeutic approaches for patients ...
Data shows Kenya was still out of the Mpox vortex as at November 10, having recorded only 17 cases out of more than 15,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback